ReoPro retavase reperfusion of stroke safety study-imaging evaluation with computed tomography (ROSIE-CT).

Trial Profile

ReoPro retavase reperfusion of stroke safety study-imaging evaluation with computed tomography (ROSIE-CT).

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Abciximab (Primary) ; Reteplase (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms ROSIE-CT
  • Most Recent Events

    • 01 Sep 2009 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Status changed from active, no longer recruiting to completed.
    • 24 Jul 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top